| Drugs with this side effect as MedDRA Preferred Term
			
			
	  	1,25(OH)2D3
				
			2-hydroxysuccinaldehyde
				
			5-ASA
				
				
					Myalgia: very rare, postmarketing, 3% - 8% 5-FU
				
			5-aza-2'-deoxycytidine
				
			5-azacytidine
				
				
					Myalgia: common, 2.17% - 15.9% A77 1726
				
			Azarga
				
			BCNU
				
			Benicar-HCT
				
			CAS 76095-16-4
				
			CAS 76420-72-9
				
			CGP 19835A
				
				
					Myalgia: very common, 31% Cancidas
				
			EACA
				
			EDTA
				
			Enfuvirtide
				
			FAMP
				
			Fe(III
				
				
					Myalgia: postmarketing, 0% - 3.6% Forteo
				
			Ge-132
				
			Goserelin
				
			Histrelin
				
			Humalog
				
			ICI 182,780
				
			Implanon
				
			Insulin
				
			K779
				
			L-Dmp
				
			LY146032
				
				
					Myalgia: postmarketing, uncommon, 1% Lantus
				
			Leuprorelin
				
				
					Myalgia: postmarketing, 3% - 9% Lisinopril
				
			Lovaza
				
			MK-462
				
			Metrodin
				
			Nafarelin
				
			Nuvocid
				
			Octreotide
				
			Oestrogen
				
			Optison
				
			PGE2
				
			Promacta
				
			SOM230
				
			SU5416
				
			Saxagliptin
				
			Signifor
				
			Supremon
				
			TMC207
				
			TMC435
				
			Triptorelin
				
			UDCA
				
				
					Myalgia: postmarketing, 5.8% - 5.81% VACV
				
			abacavir
				
			abacavir-lamivudine
				
			abiraterone
				
			acamprosate
				
			acebutolol
				
			acipimox
				
			acitretin
				
			actinomycin D
				
			acyclovir
				
			adefovir dipivoxil
				
			alendronate
				
				
					Myalgia: postmarketing, 0% - 1.1% allopurinol
				
			almotriptan
				
				
					Myalgia: postmarketing, infrequent alosetron
				
			alprazolam
				
			ambrisentan
				
			aminoglutethimide
				
			amlodipine
				
			amlodipine besylate
				
			amphotericin B
				
			amprenavir
				
			anagrelide
				
			anastrozole
				
				
					Myalgia: postmarketing, 5.17% - 5-36% anthracycline
				
			apraclonidine
				
			aprepitant
				
			aripiprazole
				
			arsenic
				
			arsenic trioxide
				
			articaine
				
			atazanavir
				
				
					Myalgia: postmarketing, uncommon atomoxetine
				
			atorvastatin
				
				
					Myalgia: postmarketing, 0% - 5.6% atovaquone
				
			avanafil
				
			axitinib
				
			azathioprine
				
			azelastine
				
			azithromycin
				
			aztreonam
				
			baclofen
				
			balsalazide
				
			benazepril
				
			benazeprilat
				
			bepridil
				
			betaxolol
				
			bexarotene
				
			bezafibrate
				
			bicalutamide
				
			bisoprolol
				
			bleomycin hydrochloride
				
			boceprevir
				
				
					Myalgia: very common, 24% bortezomib
				
			bosutinib
				
			brimonidine
				
			brinzolamide
				
			bromcresol green
				
			budesonide
				
			buprenorphine
				
			bupropion
				
				
					Myalgia: postmarketing, 1.6% - 6% buspirone
				
			busulfan
				
			cabazitaxel
				
			candesartan
				
			candesartan cilexetil
				
			capecitabine
				
			captopril
				
			carbamazepine
				
			carbimazole
				
			carboplatin
				
			carboprost
				
			carnitine
				
			carvedilol
				
			cefaclor
				
			cefditoren
				
			cefpodoxime
				
			celecoxib
				
			cerivastatin
				
			cetirizine
				
			cevimeline
				
			chlorhexidine
				
			cidofovir
				
			cilazapril
				
			cilostazol
				
			cimetidine
				
			cinacalcet
				
				
					Myalgia: postmarketing, common, 15% ciprofloxacin
				
				
					Myalgia: postmarketing, rare cisplatin
				
			citalopram
				
				
					Myalgia: infrequent, uncommon, frequent, 1.9% - 2% cladribine
				
			clarithromycin
				
			clobazam
				
			clofarabine
				
			clomiphene citrate
				
			clomipramine
				
			clonazepam
				
			clopidogrel
				
				
					Myalgia: very rare, postmarketing clozapine
				
			cobicistat
				
			colchicine
				
			colesevelam
				
			conjugated estrogens
				
			copolymer 1
				
			cortisol
				
			cyanocobalamin
				
			cyclobenzaprine
				
			cyclophosphamide
				
			cytarabine
				
			dabrafenib
				
				
					Myalgia: very common, 0% - 24% dacarbazine
				
			dantrolene
				
			darunavir
				
			dasatinib
				
				
					Myalgia: common, 0% - 13% deferoxamine
				
			delamanid
				
			delavirdine
				
			delta 9-THC
				
			demethyl
				
			deprenyl
				
			desflurane
				
			desloratadine
				
			desmopressin
				
			dexamethasone
				
			dexamethasone sodium phosphate
				
			dexrazoxane
				
			diazepam
				
			diclofenac
				
				
					Myalgia: postmarketing, 0% - 3% dicloxacillin
				
			didanosine
				
			diethylpropion
				
			dihydroergotamine
				
			diltiazem
				
				
					Myalgia: postmarketing, 0% - 2.31% dipyridamole
				
			docetaxel
				
			dolasetron
				
			donepezil
				
			doxazosin
				
			doxepin
				
			doxercalciferol
				
			doxorubicin
				
			doxycycline
				
			doxycycline hyclate
				
			duloxetine
				
			efavirenz
				
			eletriptan
				
			eltrombopag
				
			emtricitabine
				
			entacapone
				
			eplerenone
				
			eprosartan
				
			ergotamine
				
			eribulin
				
			erlotinib
				
			eslicarbazepine acetate
				
			esomeprazole magnesium
				
			estazolam
				
			estradiol
				
				
					Myalgia: postmarketing, 1.72% - 5.62% etodolac
				
			everolimus
				
				
					Myalgia: common, 1.66% - 7.17% exemestane
				
				
					Myalgia: very common, 5.5% - 2-33% ezetimibe
				
				
					Myalgia: postmarketing, 0.5% - 3.2% famciclovir
				
				
					Myalgia: very rare, postmarketing famotidine
				
			febuxostat
				
			felbamate
				
			felodipine
				
			fenofibrate
				
				
					Myalgia: postmarketing, uncommon, 0.629% - 6.12% fenofibric acid
				
				
					Myalgia: postmarketing, 3.07% - 6.12% fentanyl
				
			ferumoxytol
				
			fexofenadine
				
			flecainide
				
			flucloxacillin
				
			fluconazole
				
				
					Myalgia: postmarketing, uncommon fludarabine
				
			fludrocortisone
				
			flunisolide
				
			fluoxetine
				
			flurbiprofen
				
			fluticasone
				
			fluvastatin
				
				
					Myalgia: postmarketing, rare, 1.5% - 5% fluvoxamine
				
				
					Myalgia: infrequent, uncommon, 2% - 5% formoterol
				
			fosamprenavir
				
			foscarnet
				
			fosfomycin
				
			fosfomycin trometamol
				
			fosinopril
				
			fosinoprilat
				
			fosphenytoin
				
			frovatriptan
				
			gabapentin
				
				
					Myalgia: infrequent, 1.9% - 2% gadobenate dimeglumine
				
			gadodiamide
				
			gadolinium
				
			gadoversetamide
				
			galantamine
				
			ganciclovir
				
			gatifloxacin
				
			gemcitabine
				
				
					Myalgia: very common, 0% - 33% gemfibrozil
				
			gemifloxacin
				
			glibenclamide
				
			gliclazide
				
			glipizide
				
			glutamine
				
			guanfacine
				
			halofantrine
				
			hepatitis B vaccines
				
			hetastarch
				
			histamine
				
			hydralazine
				
			hydrochlorothiazide
				
			hydrocodone
				
			hydromorphone
				
			hydroxybutyrate
				
			ibandronate
				
				
					Myalgia: postmarketing, 0.8% - 6% ibuprofen
				
			icodextrin
				
			ifosfamide
				
			iloperidone
				
			imatinib
				
				
					Myalgia: very common, 0% - 38.8% imiquimod
				
			indacaterol
				
			indapamide
				
			indinavir
				
			insulin detemir
				
			iopamidol
				
			ipratropium bromide
				
			irbesartan
				
				
					Myalgia: postmarketing, rare irbesartan-hydrochlorothiazide
				
			iron sucrose
				
			isomannide
				
			isosorbide-5-mononitrate
				
			itraconazole
				
				
					Myalgia: postmarketing, 1% ivacaftor
				
			ivermectin
				
			ixabepilone
				
			ketoconazole
				
			ketoprofen
				
			ketorolac
				
			ketorolac tromethamine
				
			lamivudine
				
				
					Myalgia: common, 2% - 11.6% lamotrigine
				
			lanreotide
				
			lansoprazole
				
			lapatinib
				
				
					Myalgia: very common, 0% - 10% leflunomide
				
			lenalidomide
				
				
					Myalgia: postmarketing, common lercanidipine
				
			letrozole
				
				
					Myalgia: common, 0.312% - 12-21% leuprorelin acetate
				
			levetiracetam
				
			levonorgestrel
				
			linagliptin
				
			lomefloxacin
				
			lomitapide
				
			loratadine
				
			lormetazepam
				
			losartan
				
			lovastatin
				
				
					Myalgia: postmarketing, 1.8% - 3% lubiprostone
				
			lurasidone
				
			maraviroc
				
			medroxyprogesterone acetate
				
			mefloquine
				
			meloxicam
				
			melphalan
				
			memantine
				
			mesna
				
			metaproterenol
				
			metformin
				
			methimazole
				
			methotrexate
				
			methyldopa
				
			methylphenidate
				
			methylprednisolone
				
			methylprednisolone sodium succinate
				
			methysergide
				
			metipranolol
				
			mianserin
				
			mifepristone
				
			minocycline
				
			mipomersen
				
			mirtazapine
				
				
					Myalgia: postmarketing, 1.99% - 2% misoprostol
				
			mitoxantrone
				
			moclobemide
				
			modafinil
				
			moexiprilat
				
			mometasone
				
			mometasone furoate
				
			montelukast
				
			moxifloxacin
				
			mycophenolate mofetil
				
			mycophenolic acid
				
			nabilone
				
			nafcillin
				
			nalmefene
				
			naltrexone
				
			naproxen
				
			naratriptan
				
			nefazodone
				
			nelarabine
				
			nelfinavir
				
			nevirapine
				
				
					Myalgia: postmarketing, common, 0.2% - 1.2% niacin
				
			nicardipine
				
			nicorandil
				
			nicotine
				
			nifedipine
				
			nilotinib
				
			nimodipine
				
			nisoldipine
				
			nitazoxanide
				
			nitrofurantoin
				
			nizatidine
				
			norfloxacin
				
			nystatin
				
			ofloxacin
				
			olanzapine
				
			olmesartan
				
				
					Myalgia: postmarketing, uncommon olmesartan medoxomil
				
			olsalazine
				
			omeprazole
				
				
					Myalgia: postmarketing, rare orlistat
				
			oseltamivir
				
			oxacillin
				
			oxaliplatin
				
			oxcarbazepine
				
			oxycodone
				
			paclitaxel
				
			paliperidone
				
			palonosetron
				
			pamidronate
				
				
					Myalgia: postmarketing, common, 0% - 26.4% pantoprazole
				
				
					Myalgia: very rare, postmarketing paricalcitol
				
			paroxetine
				
				
					Myalgia: rare, common, 5% pazopanib
				
			pemetrexed
				
			penicillin
				
			pentamidine
				
			pentosan polysulfate
				
			pentostatin
				
			pentoxifylline
				
			perampanel
				
			pergolide
				
			perindopril
				
			perindopril erbumine
				
			perindoprilat
				
			phenobarbital
				
			phenytoin
				
			pilocarpine
				
			pimozide
				
			pindolol
				
			pioglitazone
				
			piperacillin
				
			pirfenidone
				
			pitavastatin
				
			pizotifen
				
			ponatinib
				
			posaconazole
				
			pramipexole
				
				
					Myalgia: 1.6% Polymyalgiapravastatin
				
				
					Myalgia: 0.6% - 2.7% Polymyalgiapraziquantel
				
			prednisolone phosphate
				
			prednisone
				
			pregabalin
				
			procainamide
				
			procarbazine
				
			progesterone
				
			propafenone
				
			propofol
				
			propylthiouracil
				
			prostacyclin
				
			pyrazinamide
				
			pyridostigmine
				
			quetiapine
				
			quinapril
				
			quinaprilat
				
			quinidine
				
			rabeprazole
				
			raloxifene
				
			raltegravir
				
			ramelteon
				
			ramipril
				
			ramiprilat
				
			ranitidine
				
			rapamycin
				
			regadenoson
				
			rescinnamine
				
			retinoic acid
				
				
					Myalgia: postmarketing, 14% ribavirin
				
				
					Myalgia: very common, 17% - 64% rifabutin
				
			rifapentine
				
			rifaximin
				
			riluzole
				
			risedronate
				
				
					Myalgia: postmarketing, 4.6% - 6.2% risperidone
				
				
					Myalgia: infrequent, 0% - 5% ritonavir
				
			rivastigmine
				
				
					Myalgia: infrequent, frequent rizatriptan
				
			rofecoxib
				
			roflumilast
				
			ropinirole
				
			ropivacaine
				
			rosiglitazone
				
			rosuvastatin
				
				
					Myalgia: postmarketing, common, 1.9% - 12.7% salbutamol
				
				
					Myalgia: postmarketing, 0% - 3.3% salmeterol
				
			salmon calcitonin acetate
				
			saquinavir
				
			sertraline
				
				
					Myalgia: postmarketing, frequent sibutramine
				
			sildenafil
				
				
					Myalgia: postmarketing, uncommon, 3% - 14% simvastatin
				
				
					Myalgia: postmarketing, 0.1% - 3.7% sitagliptin
				
			sodium cromoglycate
				
			sodium ferric gluconate
				
			sofosbuvir
				
				
					Myalgia: common, very common, 0% - 16% sorafenib
				
				
					Myalgia: postmarketing, common sotalol
				
			sparfloxacin
				
			stavudine
				
				
					Myalgia: postmarketing, uncommon strontium ranelate
				
			succinylcholine
				
			sulfamethoxazole
				
			sulindac
				
			sumatriptan
				
				
					Myalgia: frequent, 0.1% - 2% sunitinib
				
			tacrolimus
				
				
					Myalgia: postmarketing, 0% - 3% tadalafil
				
			tamoxifen
				
			tamsulosin
				
			tegaserod
				
			telavancin
				
			telithromycin
				
			telmisartan
				
				
					Myalgia: postmarketing, uncommon, common, 1.1% temozolomide
				
				
					Myalgia: uncommon, common, 1% - 5.06% temsirolimus
				
			tenofovir
				
			tenofovir disoproxil fumarate
				
			terazosin
				
			terbinafine
				
				
					Myalgia: postmarketing, very common terconazole
				
			tesamorelin
				
			testosterone
				
			testosterone enanthate
				
			testosterone propionate
				
			testosterone undecanoate
				
			thalidomide
				
			thiotepa
				
			thymidine
				
			tiagabine
				
			tibolone
				
			ticlopidine
				
			tigecycline
				
			tiludronate
				
			timolol
				
			tinidazole
				
			tiopronin
				
			tiotropium
				
			tipranavir
				
			tobramycin
				
			tolcapone
				
			topiramate
				
				
					Myalgia: postmarketing, 2% - 2.5% topotecan
				
			torasemide
				
			trabectedin
				
			tramadol
				
				
					Myalgia: postmarketing, uncommon trametinib
				
			trandolapril
				
				
					Myalgia: postmarketing, 4.7% trandolaprilat
				
			tranexamic acid
				
			trans 4-cyclohexyl-L-proline
				
			travoprost
				
			trazodone
				
			treprostinil
				
			triamcinolone
				
			triamcinolone acetonide
				
			trien
				
			trimethoprim
				
			trimethoprim-sulfamethoxazole
				
			trovafloxacin
				
			umeclidinium
				
			ustekinumab
				
			v 1784
				
				
					Myalgia: postmarketing, common valdecoxib
				
			valproate
				
			valrubicin
				
			valsartan
				
			vardenafil
				
			varenicline
				
			vemurafenib
				
				
					Myalgia: postmarketing, 0% - 24% venlafaxine
				
			verapamil
				
			vigabatrin
				
			vincristine
				
			vinflunine
				
			vinorelbine
				
				
					Myalgia: postmarketing, 0% - 3% vismodegib
				
			voriconazole
				
			x M22
				
			zafirlukast
				
			zalcitabine
				
			zaleplon
				
			zanamivir
				
			ziconotide
				
			zidovudine
				
			zidovudine/lamivudine
				
			zileuton
				
			ziprasidone
				
			zoledronic acid
				
				
					Myalgia: postmarketing, common, very common, 4% - 22.7% zolmitriptan
				
				
					Myalgia: infrequent, 1% - 2% zolpidem
				
				
					Myalgia: frequent, 1% - 7% zonisamide
				
			zopiclone
				
			zuclopenthixol
				
			 | Drugs with this indication |